Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novocure Ltd Ord Sh (NQ: NVCR )

16.15 -0.48 (-2.89%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,991,204
Open 16.65
Bid (Size) 16.25 (2)
Ask (Size) 16.99 (40)
Prev. Close 16.63
Today's Range 16.06 - 16.79
52wk Range 16.06 - 120.03
Shares Outstanding 103,647,871
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Novocure Announces Presence at American Society for Radiation Oncology (ASTRO) 2023 Annual Meeting
From Novocure
Via Business Wire
Stocks That Hit 52-Week Lows On Friday
  Friday's session saw 112 companies set new 52-week lows. 
Via Benzinga

Performance

YTD
-76.23%
-76.23%
1 Month
-26.79%
-26.79%
3 Month
-61.87%
-61.87%
6 Month
-73.16%
-73.16%
1 Year
-78.74%
-78.74%

More News

Read More
3 Things About NovoCure That Smart Investors Know
Via The Motley Fool
Why Novocure Stock Fell 24.4% This Week
Via The Motley Fool
What 11 Analyst Ratings Have To Say About NovoCure
Via Benzinga
Why NovoCure Stock Is Crashing Today
Via The Motley Fool
Novocure Highlights Use of Tumor Treating Fields Therapy in Treatment of Non-Small Cell Lung Cancer at 2023 World Conference on Lung Cancer
From Novocure
Via Business Wire
3 Healthcare Stocks to Sell in September Before They Crash & Burn
Via InvestorPlace
Down 31% in 1 Day, What's Next for NovoCure Stock?
Via The Motley Fool
Is NovoCure's Stock Headed for a Free Fall?
Via The Motley Fool
Novocure Announces The Lancet Oncology Publishes Primary Data from Phase 3 LUNAR Clinical Trial in Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies
From Novocure
Via Business Wire
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
What's Going On With NovoCure Stock Today?
Via Benzinga
PDD Holdings, UP Fintech Holding, Big Lots And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Topics Stocks
Exposures US Equities
Dow Gains Over 100 Points; Hawaiian Electric Shares Surge
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is Novocure (NVCR) Stock Down 30% Today?
Via InvestorPlace
Why Is Cancer Focused-Novocure's Stock Plunging Today?
Via Benzinga
Why NovoCure Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Crude Oil Rises; GD Culture Group Shares Spike Higher
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Benzinga's Top Ratings Upgrades, Downgrades For August 28, 2023
Via Benzinga
US Stocks Open Higher; Kimco Realty To Acquire RPT Realty
Via Benzinga
Topics Stocks
Exposures US Equities
Novocure Plummets 34% After Its Cancer Treatment Fails In Ovarian Cancer
Via Investor's Business Daily
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Novocure Provides Update on Phase 3 ENGOT-ov50 / GOG-3029 / INNOVATE-3 Trial Evaluating Tumor Treating Fields Therapy in Platinum-resistant Ovarian Cancer
From Novocure
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.